MedTrace Logo

Impact of Malaria on Pregnant Women in Ouelessebougou, Mali

NCT02974608 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7691

Last updated 2023-03-23

No results posted yet for this study

Summary

Background:

Malaria is a serious disease. It is passed by infected mosquitoes. In many parts of Africa, malaria continues to be the main cause of death in young children and pregnant women. Researchers want to find out more about how malaria affects pregnant women and their babies.

Objectives:

To study the rate of miscarriage and stillbirth during the second and third trimesters among women in a certain district in Mali. To study rates of malaria infection over time among pregnant women and children in this area.

Eligibility:

Pregnant women of any age and pregnancy stage and their newborns. They must live in Ouelessebougou, Mali. Children up to 10 years old who live there.

Design:

Information about the study will be shared at community meetings, during visits to the health centers, and during census updates.

Participants will read and sign a consent form.

Pregnant women will be screened to see if they are eligible. They may have a urine test. They may have an ultrasound to date their pregnancy. Ultrasound uses sound waves to take pictures of the body.

Women will be enrolled in the study after they have their babies.

Participants may have a physical exam.

Some participants will provide a finger/heel prick blood sample.

Participants will complete a questionnaire. They will be asked about:

Medical history

Antimalarial and other interventions

Socioeconomic status

Their pregnancy

Previous pregnancies

Health of their newborn...

Conditions

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    lead NIH

Principal Investigators

  • Michal Fried, Ph.D. · National Institute of Allergy and Infectious Diseases (NIAID)

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-15
Primary Completion
2021-10-20
Completion
2022-04-21

Countries

  • Mali

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02974608 on ClinicalTrials.gov